(-0.03%) 5 098.44 points
(0.16%) 38 301 points
(-0.06%) 15 918 points
(-1.31%) $82.75
(6.19%) $2.04
(-0.03%) $2 346.40
(-0.24%) $27.47
(3.77%) $956.90
(-0.18%) $0.933
(-0.27%) $10.99
(-0.50%) $0.796
(1.73%) $93.46
-3.93% INR 1 624.80
Live Chart Being Loaded With Signals
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare...
Stats | |
---|---|
Dagens volum | 16 327.00 |
Gjennomsnittsvolum | 9 665.00 |
Markedsverdi | 13.82B |
EPS | INR0 ( 2024-02-02 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-14 |
Last Dividend | INR8.00 ( 2023-09-13 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 72.25 |
ATR14 | INR1.080 (0.07%) |
Volum Korrelasjon
Hester Biosciences Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Hester Biosciences Korrelasjon - Valuta/Råvare
Hester Biosciences Økonomi
Annual | 2022 |
Omsetning: | INR2.66B |
Bruttogevinst: | INR1.89B (70.88 %) |
EPS: | INR31.30 |
FY | 2022 |
Omsetning: | INR2.66B |
Bruttogevinst: | INR1.89B (70.88 %) |
EPS: | INR31.30 |
FY | 2022 |
Omsetning: | INR2.35B |
Bruttogevinst: | INR1.66B (70.70 %) |
EPS: | INR46.22 |
FY | 2021 |
Omsetning: | INR2.14B |
Bruttogevinst: | INR1.58B (73.69 %) |
EPS: | INR40.47 |
Financial Reports:
No articles found.
Hester Biosciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR8.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR3.10 | 2015-09-10 |
Last Dividend | INR8.00 | 2023-09-13 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | INR68.10 | -- |
Avg. Dividend % Per Year | 0.31% | -- |
Score | 1.73 | -- |
Div. Sustainability Score | 3.34 | |
Div.Growth Potential Score | 3.09 | |
Div. Directional Score | 3.21 | -- |
Year | Amount | Yield |
---|---|---|
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR10.00 | 0.65% |
2019 | INR7.00 | 0.60% |
2020 | INR6.60 | 0.46% |
2021 | INR10.00 | 0.59% |
2022 | INR10.00 | 0.40% |
2023 | INR8.00 | 0.45% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SPIC.NS | Dividend Junior | 2023-09-20 | Annually | 3 | 0.70% | |
MPHASIS.NS | Dividend Knight | 2023-07-05 | Annually | 20 | 1.43% | |
HESTERBIO.NS | Dividend Junior | 2023-09-13 | Annually | 10 | 0.31% | |
BIRLACABLE.NS | Dividend Junior | 2023-09-04 | Sporadic | 11 | 0.93% | |
RAYMOND.NS | Dividend Junior | 2023-06-23 | Sporadic | 29 | 0.15% | |
KOTARISUG.NS | Dividend Junior | 2023-08-03 | Sporadic | 11 | 0.58% | |
EVERESTIND.NS | Dividend Junior | 2023-08-14 | Annually | 22 | 0.75% | |
AMBIKCO.NS | Dividend Junior | 2023-09-22 | Annually | 17 | 1.61% | |
SYRMA.NS | No Dividend Player | 2023-09-01 | Insufficient data to determine frequency | 2 | 0.18% | |
NEWGEN.NS | Dividend Junior | 2023-06-20 | Annually | 7 | 2.26% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0631 | 1.500 | 8.74 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0640 | 1.500 | -0.400 | -0.600 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 3.05 | 1.000 | 9.98 | 9.98 | [3 - 30] |
operatingCashFlowPerShareTTM | 44.19 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 44.19 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.671 | 1.000 | 2.15 | 2.15 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.148 | 1.000 | 9.04 | 9.04 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 77.78 | 1.000 | 2.24 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0640 | 2.50 | -0.257 | -0.600 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 44.19 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.474 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 44.19 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -2.41 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.128 | 1.000 | 9.29 | 0 | [0.1 - 0.5] |
Total Score | 3.09 |
Hester Biosciences
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.